Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

Related Articles by Review for PubMed (Select 20740617)

1.

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.

Terrier B, Launay D, Kaplanski G, Hot A, Larroche C, Cathébras P, Combe B, de Jaureguiberry JP, Meyer O, Schaeverbeke T, Somogyi A, Tricot L, Zénone T, Ravaud P, Gottenberg JE, Mariette X, Cacoub P.

Arthritis Care Res (Hoboken). 2010 Dec;62(12):1787-95. doi: 10.1002/acr.20318.

PMID:
20740617
2.

Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature.

Wink F, Houtman PM, Jansen TL.

Clin Rheumatol. 2011 Feb;30(2):293-300. doi: 10.1007/s10067-010-1612-2. Epub 2010 Oct 31. Review.

PMID:
21053035
3.

Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D.

Ann Rheum Dis. 2008 Mar;67(3):283-7. Epub 2007 Jul 20. Review.

4.

Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S.

Autoimmun Rev. 2011 Nov;11(1):48-55. doi: 10.1016/j.autrev.2011.07.005. Epub 2011 Jul 24. Review.

PMID:
21821153
5.

Cryoglobulinemia vasculitis: an update.

Terrier B, Cacoub P.

Curr Opin Rheumatol. 2013 Jan;25(1):10-8. doi: 10.1097/BOR.0b013e32835b15f7. Review.

PMID:
23196322
6.
7.

Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.

Roccatello D, Baldovino S, Rossi D, Giachino O, Mansouri M, Naretto C, Di Simone D, Francica S, Cavallo R, Alpa M, Napoli F, Sena LM.

Clin Rev Allergy Immunol. 2008 Feb;34(1):111-7. doi: 10.1007/s12016-007-8019-0. Review.

PMID:
18270864
8.

Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.

Perez-Alamino R, Espinoza LR.

Curr Rheumatol Rep. 2014 May;16(5):420. doi: 10.1007/s11926-014-0420-0. Review.

PMID:
24647999
9.

[The role of rituximab in the treatment of ANCA-associated systemic vasculitis].

Roccatello D, Vangelista A, Pani A.

G Ital Nefrol. 2011 Sep-Oct;28(5):474-88. Review. Italian.

PMID:
22028261
10.

[Kidney involvement in mixed cryoglobulinemia: which treatment?].

Cacoub P.

Presse Med. 2012 Mar;41(3 Pt 1):254-9. doi: 10.1016/j.lpm.2011.11.005. Epub 2011 Dec 20. Review. French.

PMID:
22192935
11.

Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.

Saadoun D, Delluc A, Piette JC, Cacoub P.

Curr Opin Rheumatol. 2008 Jan;20(1):23-8. doi: 10.1097/BOR.0b013e3282f1330c. Review.

PMID:
18281853
12.

Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab.

Koukoulaki M, Abeygunasekara SC, Smith KG, Jayne DR.

Nephrol Dial Transplant. 2005 Jan;20(1):213-6. Review. No abstract available.

13.

Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review.

Besada E, Vik A, Koldingsnes W, Nossent JC.

Int J Hematol. 2013 Jun;97(6):800-3. doi: 10.1007/s12185-013-1323-y. Epub 2013 Apr 25. Review.

PMID:
23616220
14.

[Rationale and clinical evidence for the use of rituximab in glomerular diseases].

Mani LY, Vogt B, Burnier M, Golshayan D.

Rev Med Suisse. 2011 Apr 13;7(290):819-24. Review. French.

PMID:
21595313
15.

Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

Terrier B, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, Lazaro E, Bridoux F, Zénone T, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Autoimmun Rev. 2014 Jun;13(6):630-4. doi: 10.1016/j.autrev.2013.11.006. Epub 2014 Jan 10. Review.

PMID:
24418300
16.

[Cryoglobulinemia].

Cacoub P, Sène D, Saadoun D.

Rev Med Interne. 2008 Mar;29(3):200-8. doi: 10.1016/j.revmed.2007.10.416. Epub 2007 Nov 20. Review. French.

PMID:
18242787
17.
18.

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, Atzeni F, Saccardo F, Quartuccio L, Bruno S, Bruno R, Campanini M, Candela M, Castelnovo L, Gabrielli A, Gaeta GB, Marson P, Mascia MT, Mazzaro C, Mazzotta F, Meroni P, Montecucco C, Ossi E, Piccinino F, Prati D, Puoti M, Riboldi P, Riva A, Roccatello D, Sagnelli E, Scaini P, Scarpato S, Sinico R, Taliani G, Tavoni A, Bonacci E, Renoldi P, Filippini D, Sarzi-Puttini P, Ferri C, Monti G, Galli M.

Autoimmun Rev. 2011 Jun;10(8):444-54. doi: 10.1016/j.autrev.2011.01.008. Epub 2011 Feb 15. Review.

PMID:
21303705
19.

Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.

Kong WY, Swaminathan R, Irish A.

Int Urol Nephrol. 2013 Jun;45(3):795-802. doi: 10.1007/s11255-012-0206-0. Epub 2012 Jul 15. Review.

PMID:
22798030
20.

Infections in vasculitis.

Guillevin L.

Best Pract Res Clin Rheumatol. 2013 Feb;27(1):19-31. doi: 10.1016/j.berh.2013.01.004. Review.

PMID:
23507054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk